Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 962 | 920 | 962 | 804 | 1105 | 2053 |
Fund Return | -3.83% | -8.02% | -3.83% | -7% | 2.02% | 7.46% |
Place in category | 197 | 191 | 197 | 110 | 93 | 25 |
% in Category | 78 | 75 | 78 | 59 | 50 | 20 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Pictet CH Institutional Swiss EquiI | 2.22B | 4.62 | -3.37 | 6.35 | ||
Pictet CH Institutional Swiss EquiP | 2.22B | 4.41 | -3.56 | 6.13 | ||
Pictet CH Institutional Swiss EquiZ | 2.22B | 5.11 | -2.91 | 6.86 | ||
Pictet CH Institutional Swiss EquID | 2.2B | 4.62 | -3.37 | 6.34 | ||
Pictet CH Institutional Swiss EquPD | 2.2B | 4.41 | -3.57 | 6.13 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CH0110869143 | 1.94B | 3.87 | -5.57 | 6.56 | ||
UBS CH Equity Fund Mid Caps Switzer | 1.48B | 2.42 | -5.93 | 7.05 | ||
Pictet CH Swiss Mid Small Cap P dy | 1.31B | -4.22 | -7.35 | 7.07 | ||
Pictet CH Swiss Mid Small Cap R dy | 1.31B | -4.68 | -7.81 | 6.53 | ||
Pictet CH Swiss Mid Small Cap Z dy | 1.32B | -2.99 | -6.37 | 8.20 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Lindt & Spruengli Part | CH0010570767 | 9.30 | 10,570.0 | +1.54% | |
Sonova H Ag | CH0012549785 | 7.16 | 318.70 | +0.54% | |
Julius Baer | CH0102484968 | 5.80 | 64.34 | +0.34% | |
Temenos Group AG | CH0012453913 | 4.93 | 78.00 | +1.17% | |
Galderma | CH1335392721 | 4.79 | 113.60 | -0.11% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | BUY |
Summary | Strong Buy | Strong Buy | Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review